Medicines That Make a Difference®

Despite the variety of antibiotics currently available, bacterial infections remain a significant and growing medical problem. Many bacterial infections are serious and require hospitalization and treatment with injectable antibiotics.

Among the most common bacterial infections are those caused by Gram-positive bacteria, which include staphylococci, streptococci and enterococci. Gram-positive infections are often serious and life-threatening. The need for more effective antibiotics is particularly acute because many Gram-positive strains, particularly many staphylococci, have become resistant to currently available antibiotics. Of particular note are infections due to methicillin-resistant Staphylococcus aureus (commonly known as MRSA). Drug resistance is especially common in hospital-acquired infections.

Antibiotic Product Candidate — Telavancin for the Treatment of Nosocomial Pneumonia
In April 2009 the U.S. Food and Drug Administration accepted for filing a New Drug Application (NDA) for telavancin for the treatment of nosocomial pneumonia. The telavancin NDA is based on data from two large, multi-center, multinational, double-blind, randomized Phase 3 clinical studies, ATTAIN 1 and ATTAIN 2, in which 1,503 patients were enrolled and treated, 464 of whom were infected with MRSA.

Antibiotic Product Candidate — TD-1792
TD-1792 is an investigational heterodimer antibiotic that combines the antibacterial activities of a glycopeptide and a beta-lactam in one molecule. The goal of the TD-1792 clinical program is to develop a next-generation antibiotic for the treatment of serious infections caused by MRSA.

©2010 Theravance, Inc. Theravance, the Theravance logo and Medicines That Make a Difference are registered trademarks of Theravance, Inc. Trademarks, trade names or service marks of other companies appearing on this website are the property of their respective owners. All rights reserved.

Terms of Use     Website Admin Contact     Theravance Contact     Site Map

By clicking on the link below, you will leave www.theravance.com.

www.VIBATIV.com